Population Effectiveness of Dolutegravir Implementation in Sub-Saharan Africa

CompletedOBSERVATIONAL
Enrollment

1,000

Participants

Timeline

Start Date

May 14, 2019

Primary Completion Date

May 31, 2023

Study Completion Date

May 31, 2023

Conditions
HIV-1-infection
Interventions
OTHER

This is an observational study only.

This is an observational study only.

Trial Locations (2)

Unknown

Africa Health Research Institute, Somkele

Mbarara University of Science and Technology, Mbarara

All Listed Sponsors
collaborator

Africa Health Research Institute

OTHER

collaborator

Mbarara University of Science and Technology

OTHER

collaborator

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

collaborator

Wellcome Trust

OTHER

collaborator

ViiV Healthcare

INDUSTRY

collaborator

Harvard Medical School (HMS and HSDM)

OTHER

collaborator

University of KwaZulu

OTHER

collaborator

Emory University

OTHER

lead

Massachusetts General Hospital

OTHER